Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 616-248-3 | CAS number: 75627-31-5
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
Key value for chemical safety assessment
Skin sensitisation
Link to relevant study records
- Endpoint:
- skin sensitisation: in vivo (non-LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- July-August 1978
- Reliability:
- 4 (not assignable)
- Rationale for reliability incl. deficiencies:
- other: No data on batchno. and limited info on composition. Limited reported study according to standard/guideline (max score can be 2).
- Reason / purpose for cross-reference:
- reference to same study
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 406 (Skin Sensitisation)
- Deviations:
- yes
- Remarks:
- observation 24 h after patch removal and not also after 48 h
- Principles of method if other than guideline:
- During the induction phase it has been stated that 0.5 ml test agent was emulsified with 0.05 ml Freund's adjuvant. This should read 0.05 ml test agent plus 0.05 ml Freund's adjuvant.
- GLP compliance:
- no
- Remarks:
- pre-GLP
- Type of study:
- guinea pig maximisation test
- Species:
- guinea pig
- Strain:
- Dunkin-Hartley
- Sex:
- female
- Details on test animals and environmental conditions:
- TEST ANIMALS
- Source: Porcellus Animals Ltd., UK
- Age at study initiation: no info
- Weight at study initiation: 300-400 g
- Housing: 5 to a cage
- Diet (e.g. ad libitum): ad lib
- Water (e.g. ad libitum): ad lib
- Acclimation period: no info
ENVIRONMENTAL CONDITIONS
- Temperature (°C): no info
- Humidity (%): no info
- Air changes (per hr): no info
- Photoperiod (hrs dark / hrs light): no info
IN-LIFE DATES: no info - Route:
- intradermal and epicutaneous
- Vehicle:
- water
- Concentration / amount:
- Intradermal induction: 0.1 ml test compound 10% (v/v)
Topical induction: 10% v/v on patch
Topical challenge: 10% v/v on patch - Route:
- epicutaneous, occlusive
- Vehicle:
- water
- Concentration / amount:
- Intradermal induction: 0.1 ml test compound 10% (v/v)
Topical induction: 10% v/v on patch
Topical challenge: 10% v/v on patch - No. of animals per dose:
- 10 in test group
5 in control group - Details on study design:
- RANGE FINDING TESTS: using 2 guinea pigs the following levels were tested for irritation: 2, 5, 10 and 20% v/v. The test compound was moderately irritant at 20%. Therefore 10% v/v was chosen as challenge concentration.
MAIN STUDY
A. INDUCTION EXPOSURE
- No. of exposures: 2 (1st intradermal, 2nd topical)
- Exposure period: single injection plus topical application for 48 h (6 days after injection)
- Test groups: test compound
- Control group: Freund's adjuvant only
- Site: 4x6 cm across the scapular region
- Concentrations: 10% v/v (injection), 10% v/v (topical)
B. CHALLENGE EXPOSURE
- No. of exposures: 1
- Day(s) of challenge: 14 days after last induction
- Exposure period: 24 h
- Test groups: 10% v/v
- Control group: 10% v/v
- Site: right flank
- Concentrations: 10% v/v
- Evaluation (hr after challenge): 24 h after patch removal
OTHER: - Challenge controls:
- yes
- Positive control substance(s):
- no
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- test chemical
- Dose level:
- 10% v/v at challenge
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Clinical observations:
- none
- Remarks on result:
- other: Reading: 1st reading. . Hours after challenge: 24.0. Group: test group. Dose level: 10% v/v at challenge. No with. + reactions: 0.0. Total no. in groups: 10.0. Clinical observations: none.
- Interpretation of results:
- not sensitising
- Remarks:
- Migrated information
- Conclusions:
- At a non-irritant concentration of 10% v/v in water, the test compound was not a sensitiser.
- Executive summary:
A study was performed to assess the contact sensitisation potential of the test material in the Dunkin-Hartley guinea pig. The study, a Guinea Pig Maximization Test, was essentially performed in compliance with the requirements of OECD 406. Ten test and five control animals were used for the main study. Based on the results of a sighting test using 2 guinea pigs, the concentration of the test compound for the induction and challenge phases were selected as follows: 10% v/v in water. This concentration was not-irritating, the next higher tested concentration of 20% v/v was moderately irritating. No reactions were observed in both test and control group. The test material, TL 856, was therefore considered a non-sensitiser to guinea pig skin.
Reference
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (not sensitising)
- Additional information:
The potential of the test item nonylphenol ethoxylate, sarcosine derivative (CAS no 75627-31-5)to induce delayed contact hypersensitivity have been evaluated in one in vitro skin sensitization study and one in vitro protein binding assay. The current state of the art understanding of the process that lead to skin sensitization and allergic skin reactions was recently published by the OECD series on testing and assessment No 168. This publication gives scientific evidence for skin sensitization is initiated by covalent binding to proteins. Although there is no OECD validated method to support this adverse outcome pathway, a non-GLP in vitro test was performed in order to support the negative in vivo test. This strategy was chosen in order to avoid repeating animal tests. In this protein binding assay, the nonylphenol ethoxylate, sarcosine derivate(CAS no 75627-31-5)showed no reactivity towards the synthetic peptide Ac-NKKCDLF at any of the tested concentrations at neither pH 7.4 nor pH 10.0. This indicates no potential to react with endogenous proteins within the skin to induce sensitizing effects under the assay conditions up to a concentration of 8 mM.
Migrated from Short description of key information:
The potential of nonylphenol ethoxylate, sarcosine derivative (CAS no 75627-31-5) to induce delayed contact hypersensitivity was evaluated in a Guinea Pig Maximization Test essentially performed in compliance with the requirements of OECD 406. The test was performed pre-GLP in a test with ten test and five control animals in the main study. Based on the results of a sighting test using 2 guinea pigs, the concentration of the test compound for the induction and challenge phases were selected as follows: 10% v/v in water. This concentration was not-irritating, the next higher tested concentration of 20% v/v was moderately irritating. No reactions were observed in both test and control group. The test material was therefore considered a non-sensitiser to guinea pig skin.
Justification for selection of skin sensitisation endpoint:
There is one in vivo skin sensitisation study available, performed on a product which contains nonylphenol ethoxylate, sarcosine derivative (CAS no 75627-31-5). The test was performed in 1978 and has validity rating 4 based on no data on batch number and limited info on composition. The report describes the test in a limited way, but it is performed according to the standards/guidelines. The test gave no indications on sensitising properties, and this result together with the newly performed in vitro protein binding test strongly supports the substance to be classified as not sensitising.
Respiratory sensitisation
Endpoint conclusion
- Endpoint conclusion:
- no study available
- Additional information:
There are no guidelines for an animal test for respiratory sensitisation, however in general respiratory sensitisers are also skin sensitisers. Nonylphenol ethoxylate, sarcosine derivate(CAS no 75627-31-5)was not found to be a skin sensitiser in the OECD 406 study, supported by the in vitro protein binding assay. This indicates that the substance is unlikely to possess any significant potential for respiratory sensitisation. Nonylphenol ethoxylate, sarcosine derivate (CAS no 75627-31-5) is produced within a ventilated factory with risk management measures in place to limit the exposure. Its use is limited to industrial settings and does not include formation of aerosols, particles or droplets of inhalable size. Exposure to humans via the inhalation route is therefore considered to be unlikely. Based on the non-skin sensitizing profile of the substance, it is not considered justified on animal welfare grounds to perform a respiratory sensitization study.
Justification for classification or non-classification
Skin
Nonylphenol ethoxylate, sarcosine derivate(CAS no 75627-31-5) was not found to be a skin sensitiser when tested according to the OECD 406 nor in the in vitro protein binding assay. There are therefore no indications that the substance should be classified according to the Globally Harmonized System of Classification and Labelling of Chemicals (GHS) of the United Nations (2011), nor the Regulation (EC) No 1272/2008 on classification, labelling and packaging of substances and mixtures.
Inhalation
Nonylphenol ethoxylate, sarcosine derivate(CAS no 75627-31-5) was not found to be a skin sensitiser which indicates that it is unlikely to possess any significant potential for respiratory sensitisation.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.